Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

<p>Abstract</p> <p>Background</p> <p>During stavudine phase-out plan in developing countries, tenofovir is used to substitute stavudine. However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofovir/lamivudine/efavirenz...

Full description

Bibliographic Details
Main Authors: Suntisuklappon Busakorn, Tantanathip Preecha, Prasithsirikul Wisit, Lueangniyomkul Aroon, Mankatitham Wiroj, Manosuthi Weerawat, Narkksoksung Anongnuch, Nilkamhang Samruay, Sungkanuparph Somnuek
Format: Article
Language:English
Published: BMC 2010-10-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/7/1/37

Similar Items

Similar Items